[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Diagnostics & Diseases Market Research Reports & Industry Analysis

Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).

A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.

This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.

Publications found: 42,431
Sort by:

2014 Analysis of the German Immunoprotein Diagnostic Testing Market: Hospitals, Commercial Labs, Physician Offices

US$ 1,960.00

This new 236-page report from Venture Planning Group provides analysis of the German immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by ...

November 2013 236 pages

2014 Analysis of the Italian Immunoprotein Diagnostic Testing Market: Hospitals and Commercial Labs

US$ 1,960.00

This new 233-page report from Venture Planning Group provides analysis of the Italian immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by ...

November 2013 233 pages

2014 Analysis of the Japanese Immunoprotein Diagnostic Testing Market: Hospitals and Commercial Labs

US$ 2,200.00

This new 234-page report from Venture Planning Group provides analysis of the Japanese immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by ...

November 2013 234 pages

2014 Analysis of the Spanish Immunoprotein Diagnostic Testing Market: Hospitals, Commercial Labs, Ambulatory Care Centers

US$ 1,960.00

This new 236-page report from Venture Planning Group provides analysis of the Spanish immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by ...

November 2013 236 pages

2014 Analysis of the UK Immunoprotein Diagnostic Testing Market: Hospitals and Commercial Labs

US$ 1,960.00

This new 234-page report from Venture Planning Group provides analysis of the UK immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by ...

November 2013 234 pages

2014 Analysis of the European Immunoprotein Diagnostic Testing Market: Hospital, Commercial Labs, Physician Offices, Ambulatory Care Centers

US$ 5,200.00

This new 273-page report from Venture Planning Group provides analysis of the European immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by ...

November 2013 273 pages

2014 Analysis of the US Enteric Disease Testing Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus,Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

US$ 4,320.00

... , sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Enteric Disease market in the US. Current scientific views on epidemiology and etiology are presented for Campylobacter, Cryptosporidium, E. Coli, ...

November 2013 314 pages

2014 Analysis of the European Enteric Disease Testing Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

US$ 7,520.00

... 363-page report from Venture Planning Group provides analysis of the European enteric disease testing market, including emerging tests, technologies, ... . About this Report This report presents detailed analysis of the Enteric Disease market in Europe (France, Germany, Italy, Spain, UK). Current scientific ...

November 2013 363 pages

2014 Analysis of the US Sexually-Transmitted Disease Testing Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis

US$ 3,600.00

... This new 278-page report from Venture Planning Group provides analysis of the US sexually-transmitted disease testing market, including emerging tests ... , and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market in the US, Current scientific views on epidemiology and ...

November 2013 278 pages

2014 Analysis of the European Sexually-Transmitted Disease Testing Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis

US$ 6,320.00

... 318-page report from Venture Planning Group provides analysis of the European sexually-transmitted disease testing market, including emerging tests, ... profiles of leading suppliers. The report presents detailed analysis of the STD market in Europe (France, Germany, Italy, Spain, UK), Current scientific views ...

November 2013 318 pages

Analysis of the Tumor Markers and Special Chemistry Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan

US$ 6,800.00

... Venture Planning Group contains 83 tables and provides analysis of the global tumor markers and special chemistry testing market, including emerging ... , such as specimen preparation devices, controls, calibrators and others. “2013 Tumor Markers and Special Chemistry Testing Market: US, Europe (France, Germany ...

November 2013 320 pages

2014 Analysis of the German Diagnostic Testing Market: Segment Forecasts and Supplier Shares

US$ 3,880.00

This new report from Venture Planning Group provides an overview of the German diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...

November 2013 61 pages

2014 Analysis of the Italian Diagnostic Testing Market: Segment Forecasts and Supplier Shares

US$ 3,880.00

This new report from Venture Planning Group provides an overview of the Italian diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry ...

November 2013 57 pages

2014 Analysis of the Japanese Diagnostic Testing Market: Segment Forecasts and Supplier Shares

US$ 3,880.00

This new report from Venture Planning Group provides an overview of the Japanese diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry ...

November 2013 60 pages

2014 Analysis of the Spanish Diagnostic Testing Market: Segment Forecasts and Supplier Shares

US$ 3,880.00

This new report from Venture Planning Group provides an overview of the Spanish diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...

November 2013 56 pages

2014 Analysis of the UK Diagnostic Testing Market: Segment Forecasts and Supplier Shares

US$ 3,880.00

This new report from Venture Planning Group provides an overview of the UK diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...

November 2013 64 pages

2014 Analysis of the US Diagnostic Testing Market: Segment Forecasts and Supplier Shares

US$ 4,320.00

This new report from Venture Planning Group provides an overview of the US diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...

November 2013 101 pages

2014 Analysis of the French Diagnostic Testing Market: Segment Forecasts and Supplier Shares

US$ 3,880.00

This new report from Venture Planning Group provides an overview of the French diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...

November 2013 58 pages

2014 Analysis of the Argentinean Cancer Diagnostics Market: Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 5,360.00

Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,350. 2014 Analysis of the Argentinean Cancer Diagnostics Market is a new strategic ... the next five years. The report examines trends in the Argentinean cancer diagnostics market; reviews current and emerging tests; analyses ...

November 2013 509 pages

2014 Analysis of Mexican Cancer Diagnostics Market: Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 5,360.00

... test volumes, sales forecasts, supplier shares) $4,350. 2014 Analysis of Mexican Cancer Diagnostics Market is a new strategic analysis of the major business opportunities emerging in the Mexican cancer diagnostics market during the next five years. The report examines trends in the Mexico cancer diagnostics ...

November 2013 510 pages

Indian In Vitro Diagnostics Market Analysis 2018

US$ 700.00

... . “Indian In Vitro Diagnostics Market Analysis 2018” research report by KuicK Research is an intriguing text that gives detailed facts and analysis on latest developments in the Indian In Vitro Diagnostics Market landscape. Report gives comprehensive insight on following issues related to development of In Vitro Diagnostics Market in India: Market Overview Market Segment Analysis by Device & Reagents Emerging Market Trends Market Future ...

November 2013 68 pages

Global Cancer Monoclonal Antibodies Pipeline Analysis

US$ 1,500.00

... Pharma gives comprehensive insight on the various Monoclonal Antibodies being developed for the treatment of Cancer. Research report covers all the ... profile in development phase are covered in “Global Cancer Monoclonal Antibodies Pipeline Analysis” research report: Drug Profile Overview Alternate Names for ...

November 2013 660 pages

Indian Diagnostic Market Outlook to 2017

US$ 900.00

... and higher efficiency systems. According to RNCOS’ report, “Indian Diagnostic Market Outlook to 2017”, the diagnostics equipment market, which is divided into In vitro ... been witnessing an increase in the number laboratory tests being outsourced to India. The coming years will see a rise in the share of the ...

October 2013 125 pages

Consensus Outlook: Prostate Cancer- Competition intensifies in race to the top

US$ 7,495.00

... the global prostate cancer market to grow from $3.5 billion in 2012 to $7.7 billion in 2017. Consensus Outlook: Prostate Cancer – Competition intensifies in race to the top analyses the global prostate cancer market players ... data analysis updates over the next 12 months Report Benefits: Consensus Outlook: Prostate Cancer – Competition intensifies in race to the top will allow you to: Evaluate future ...

October 2013

China Diabetes Market Outlook 2018

US$ 1,000.00

... to reach approximately US$ 4.6 Billion by 2018. In RNCOS’ latest report “China Diabetes Market Outlook 2018”, the country’s diabetes market has been segmented ... been extending their product portfolios in order to gain their own market shares. In the end, RNCOS concludes with a competitive analysis of major ...

October 2013 50 pages

Emerging NIPT Market in Asia Pacific

US$ 1,200.00

... study, we have selected the APAC region since it represents a highly underpenetrated market with immense potential for growth. APAC houses almost a third of global population. According to our report, “Emerging NIPT Market in Asia Pacific” there are around 1 Million potential patients in the region ...

October 2013 50 pages

Physician Views: How have cardiologists, internal medicine specialists and general practitioners reacted to the new AHA/ACC cholesterol management guidelines

US$ 695.00

... Key questions focus on how enthusiastically the guidelines will be embraced by physicians and how rapidly. In a note to ... the PCSK9 inhibitors, a number of analysts have pointed out, however, that initial ... inhibitors. This week’s Physician Views poll will ask US-based cardiologists, general practioners and ...

October 2013

Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global

US$ 1,590.00

... in the world, behind only heart disease. More people die from cancer every year around the world than AIDS, Tuberculosis and Malaria ... Cancer Test Market & Forecast Breast Cancer Test Market & Forecast Cervical Cancer Test Market & Forecast Colorectal (Colon) Cancer Test Market & Forecast Ovarian Cancer ...

October 2013 277 pages

China Food Safety Testing Industry Report, 2013-2015

US$ 2,200.00

... from testing of agricultural and livestock products in the early 1900s. With the issuance of Chinese food safety related laws and regulations as well as the enhancement of food safety supervision, China food safety testing industry has developed rapidly. In 2009-2012, China food ...

October 2013 98 pages

2014 Analysis of the Global Clinical Chemistry and Immunodiagnostic Market: France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 26,800.00

... Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of clinical chemistry and immunodiagnostic products by country and individual product ...

October 2013 1115 pages

2014 Analysis of the European Clinical Chemistry and Immunodiagnostic Market: France, Germany, Italy, Spain, UK, Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 15,760.00

... forecasts, supplier shares) $12,800. This comprehensive five-country report contains 900 pages and 335 tables. The report explores future trends in the European countries (France, Germany, Italy, Spain, UK); provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and ...

October 2013 900 pages

2014 Analysis of the French Clinical Chemistry and Immunodiagnostic Market: Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 4,880.00

... and 104 tables. The report explores future trends in the French market; provides estimates of the specimen, test and sales volumes, ... segment: Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review ...

October 2013 542 pages

2014 Analysis of the German Clinical Chemistry and Immunodiagnostic Market: Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 4,880.00

... pages and 119 tables. The report explores future trends in the German market; provides estimates of the specimen, test and sales volumes, ... Laboratories Physician Offices/Group Practices Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review ...

October 2013 578 pages

2014 Analysis of the Italian Clinical Chemistry and Immunodiagnostic Market: Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 4,880.00

... and 103 tables. The report explores future trends in the Italian market; provides estimates of the specimen, test and sales volumes, ... segment: Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review ...

October 2013 561 pages

2014 Analysis of the Japanese Clinical Chemistry and Immunodiagnostic Market: Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 6,080.00

... and 103 tables. The report explores future trends in the Japanese market; provides estimates of the specimen, test and sales volumes ... segment: Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review ...

October 2013 559 pages

2014 Analysis of the Spanish Clinical Chemistry and Immunodiagnostic Market: Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 4,880.00

... pages and 117 tables. The report explores future trends in the Spanish market; provides estimates of the specimen, test and sales volumes, ... /Private Laboratories Ambulatory Care Centers Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review ...

October 2013 568 pages

2014 Analysis of the UK Clinical Chemistry and Immunodiagnostic Market: Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 4,880.00

... , cancer, immunoprotein and abused drug assays, by market segment: Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and a feature comparison of high-, ...

October 2013 563 pages

2014 Analysis of the US Clinical Chemistry and Immunodiagnostic Market: Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 9,200.00

... abused drug assays, by market segment: Hospitals Commercial/Private Laboratories Physician Offices/Group Practices Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and a feature comparison of ...

October 2013 600 pages

2014 Analysis of the Global Transfusion Diagnostics Market: France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 26,000.00

... NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ... Commercial/Private Laboratories Military Blood Banks Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious disease ...

October 2013 800 pages

2014 Analysis of the European Transfusion Diagnostics Market: France, Germany, Italy, Spain, UK Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 15,760.00

... and potential market entrants identify and evaluate emerging opportunities in the European transfusion diagnostic market during the next five years, and assist ... B19 NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ...

October 2013 600 pages

2014 Analysis of the French Transfusion Diagnostics Market: Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 4,880.00

... NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ... Centers Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious disease ...

October 2013 430 pages

2014 Analysis of the German Transfusion Diagnostics Market: Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 4,880.00

... NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ... Centers Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious disease ...

October 2013 426 pages

2014 Analysis of the Italian Transfusion Diagnostics Market: Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 4,880.00

... NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ... Centers Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious disease ...

October 2013 412 pages

2014 Analysis of the Japanese Transfusion Diagnostics Market: Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 6,160.00

... NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ... Centers Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious disease ...

October 2013 426 pages

2014 Analysis of the Spanish Transfusion Diagnostics Market: Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 4,880.00

... NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ... Centers Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious disease ...

October 2013 425 pages

2014 Analysis of the UK Transfusion Diagnostics Market: Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 4,880.00

... NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ... Centers Hospitals Commercial/Private Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious disease ...

October 2013 422 pages

2014 Analysis of the US Transfusion Diagnostics Market: Sales Forecasts, Supplier Shares, Competitive Strategies

US$ 7,760.00

... NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of transfusion ... Commercial/Private Laboratories Military Blood Banks Current and Emerging Products Analysis of current and emerging blood typing, grouping and infectious disease ...

October 2013 460 pages

Therapy Class Overview : Hepatitis C Virus Infection

US$ 1,000.00

... Oral IFN –Free combinations for Treatment of HCV and ROW opportunity Competitive Landscape - IFN-Free drugs HCV Vaccines and their progress Difficult to treat and drugs for HCV-HIV co infection Market ...

October 2013 33 pages

Physician Views: How do oncologists use companion diagnostics, what are the key challenges and which pharma companies are best at supporting them?

US$ 695.00

... be done to improve how these predictive tools can be used? This week's Physician Views poll asks oncologists based in the US and 5EU markets: How many cancer patients they assess with a companion diagnostic prior to treatment? How the ...

September 2013

Colorectal Cancer - KOL Insight Module

US$ 7,495.00

The global market for colorectal cancer (CRC) drugs is undergoing a fundamental shift due to wider generic competition in ... clinical opinion This new KOL Insight report Colorectal Cancer - EGFR inhibitors on the verge of growth provides everyone interested in this dynamic cancer sector with a complete ...

September 2013 127 pages

Filters

Search

Categories

675
84
1,065
32,726
152
69
819
657
1,863
4,251
70

Publishers

8
9
35
1
15
4
40
1
1
17
12
4
1
1
13
2
1
53
1
1
9
9
328
1
2
1
5
16
1
1
13
4
40
1
2
8
5
16
19
36
7
10
6
2
3
174
108
13
53
3
29
15
1
4
7
18
3
24
3
32
1
15
2
7
2
81
46
11
77
1
14
2
22
3
74
40,332
1
40
2
17
15
24
85
6
10
50
11
62
48
1
45
23
49

Regions

280
15
1
134
138
137
137
136
136
135
134
131
130
175
38
15,523
447
192
191
191
137
4
3
2
198
197
196
196
196
195
194
194
194
192
106
193
195
193
192
107
195
138
203
194
189
200
198
196
139
105
195
194
194
193
195
176
198
197
138
112
197
197
195
195
193
193
138
138
136
135
135
1
1
200
198
197
195
194
198
197
196
195
195
195
194
194
194
195
195
191
138
138
137
108
16
1
1
198
1
108
1,215
1,213
1,197
1,192
1,172
245
2
263
194
195
203
197
1,227
1,153
1,668

Price

Date

Pages

Offers

33
6
1
15
84